The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10284342" target="_blank" >RIV/00216208:11110/14:10284342 - isvavai.cz</a>
Alternative codes found
RIV/61383082:_____/14:#0000272 RIV/00216224:14110/14:00075468 RIV/65269705:_____/14:00062681 RIV/00023001:_____/14:00059022 RIV/75010330:_____/14:00010739
Result on the web
<a href="http://dx.doi.org/10.1111/jvh.12248" target="_blank" >http://dx.doi.org/10.1111/jvh.12248</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/jvh.12248" target="_blank" >10.1111/jvh.12248</a>
Alternative languages
Result language
angličtina
Original language name
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Original language description
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the modelwas used to estimate the change in the total number of HCV infections, the disease progression and mortality in 2013-2030. Finally, expert panel consensus was used to capture current treatment practices in each country. Using today's treatment paradigm,the total number of HCV infections is projected to decline or remain flat in all countries studied. However, in the same time period, the number of individuals with late-stage liver disease is projected to increase. This study concluded that the currenttreatment rate and efficacy are not sufficient to manage the disease burden of HCV. Thus, alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver-related deaths from increasing.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Viral Hepatitis
ISSN
1352-0504
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
Supp. 1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
26
Pages from-to
34-59
UT code for WoS article
000333893200003
EID of the result in the Scopus database
—